Cancer Research Cell Death Mechanisms and Cancer Therapy  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 2255-2259, September 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schwartz, S. A.
Right arrow Articles by Kirsten, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schwartz, S. A.
Right arrow Articles by Kirsten, W. H.

Endogenous Type C Particles from Rat Embryo Cells Treated with 5-Bromodeoxyuridine1

S. A. Schwartz, S. Panem, E. Stefanski2 and W. H. Kirsten3

Departments of Pathology [S. A. S., S. P., E. S., W. H. K.] and Pediatrics [W. H. K.], Division of Biological Sciences, University of Chicago, Chicago, Illinois 60637

Type C particles were released from secondary W/Fu rat embryo cell cultures following exposure to 10-4 M 5-bromodeoxyuridine for 36 hr. The particles were first detected in culture fluids by electron microscopy and uridine-3H labeling 2 days after drug treatment. Maximal release of type C particles occurred between 8 and 10 days. All rat embryo cells treated with 5-bromodeoxyuridine eventually fluoresced against antiserum to antigens from 2 mouse leukemia viruses. Fewer than 1% of the analog-treated cells contained budding particles as judged from electron microscopy. The induced type C particles banded at buoyant densities of 1.16 to 1.18 g/ml in sucrose equilibrium gradients. Culture fluids from 5-bromodeoxyuridine-treated rat embryo cells contained DNA polymerase activity. The type C particles failed to transform mouse or rat cells in vitro and did not induce neoplasms in neonatal mice or rats. 5-bromodeoxyuridine-treated rat embryo cells were not tumorigenic when injected into syngeneic newborns.

1 This investigation was supported by USPHS Grant CA-14599 from the National Cancer Institute.

2 Predoctoral trainee supported by NIH Training Grant HD-00297 from the National Institute of Child Health and Human Development.

3 Joseph P. Kennedy, Jr., Mental Retardation Research Center.

Received 3/14/74. Accepted 5/20/74.




This article has been cited by other articles:


Home page
ScienceHome page
S Panem, E. Prochownik, F. Reale, and W. Kirsten
Isolation of type C virions from a normal human fibroblast strain
Science, July 25, 1975; 189(4199): 297 - 299.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.